Favorable response to erlotinib in a lung adenocarcinoma with both epidermal growth factor receptor exon 19 deletion and K-ras G13D mutations

研究成果: 雜誌貢獻文章

16 引文 (Scopus)
原文英語
期刊Journal of Clinical Oncology
28
發行號7
DOIs
出版狀態已發佈 - 三月 1 2010

指紋

Proto-Oncogene Proteins
Quinazolines
ras Proteins
Gene Deletion
Protein Kinase Inhibitors
Epidermal Growth Factor Receptor
Exons
Lung Neoplasms
Adenocarcinoma
Mutation
Erlotinib Hydrochloride
Adenocarcinoma of lung

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Medicine(all)

引用此文

@article{02ca571751ea4fb4b41804b0de2b382b,
title = "Favorable response to erlotinib in a lung adenocarcinoma with both epidermal growth factor receptor exon 19 deletion and K-ras G13D mutations",
author = "Chun-Nin Lee and Chen, {Hsiang Yin} and Liu, {H. Eugene}",
year = "2010",
month = "3",
day = "1",
doi = "10.1200/JCO.2009.24.0747",
language = "English",
volume = "28",
journal = "Journal of Clinical Oncology",
issn = "0732-183X",
publisher = "American Society of Clinical Oncology",
number = "7",

}

TY - JOUR

T1 - Favorable response to erlotinib in a lung adenocarcinoma with both epidermal growth factor receptor exon 19 deletion and K-ras G13D mutations

AU - Lee, Chun-Nin

AU - Chen, Hsiang Yin

AU - Liu, H. Eugene

PY - 2010/3/1

Y1 - 2010/3/1

UR - http://www.scopus.com/inward/record.url?scp=77949885180&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77949885180&partnerID=8YFLogxK

U2 - 10.1200/JCO.2009.24.0747

DO - 10.1200/JCO.2009.24.0747

M3 - Article

VL - 28

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

SN - 0732-183X

IS - 7

ER -